Lee Ainslie's CRBU Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 652,542 shares of Caribou Biosciences, Inc. (CRBU) worth $1.15 M, representing 0.01% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in CRBU, demonstrating sustained confidence in this investment. Largest reduction occurred in Q4 2021, reducing 300,000 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Caribou Biosciences (CRBU) Holding Value Over Time
Track share changes against reported price movement
Quarterly Caribou Biosciences (CRBU) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2021 | -300,000 | Reduce 31.49% | 652,542 | $14.94 |
| Q3 2021 | +952,542 | New Buy | 952,542 | $22.87 |
Lee Ainslie's Caribou Biosciences Investment FAQs
Lee Ainslie first purchased Caribou Biosciences, Inc. (CRBU) in Q3 2021, acquiring 952,542 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Caribou Biosciences, Inc. (CRBU) for 20 quarters since Q3 2021.
Lee Ainslie's largest addition to Caribou Biosciences, Inc. (CRBU) was in Q3 2021, adding 952,542 shares worth $21.78 M.
According to the latest 13F filing for Q2 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 652,542 shares of Caribou Biosciences, Inc. (CRBU), valued at approximately $1.15 M.
As of the Q2 2026 filing, Caribou Biosciences, Inc. (CRBU) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Caribou Biosciences, Inc. (CRBU) was 952,542 shares, as reported at the end of Q3 2021.